Asset Allocation & Management Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-340
Closed -$313K 82
2026
Q1
$313K Hold
340
0.12% 72
2025
Q4
$365K Hold
340
0.15% 62
2025
Q3
$259K Hold
340
0.11% 78
2025
Q2
$265K Hold
340
0.12% 76
2025
Q1
$281K Hold
340
0.14% 73
2024
Q4
$262K Buy
+340
New +$282K 0.14% 70
2022
Q3
Sell
-3,696
Closed -$1.2M 123
2022
Q2
$1.2M Hold
3,696
0.5% 30
2022
Q1
$1.06M Hold
3,696
0.38% 50
2021
Q4
$1.02M Buy
+3,696
New +$937K 0.35% 57
2020
Q2
Sell
-2,100
Closed -$291K 48
2020
Q1
$291K Buy
2,100
+572
+37% +$78.6K 0.14% 41
2019
Q4
$201K Buy
+1,528
New +$177K 0.08% 62

Other funds holding LLY

Asset Allocation & Management Company's LLY Position: Q2 2026 in Review

Asset Allocation & Management Company sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 340 shares — an estimated $313K sold.

Asset Allocation & Management Company first reported a position in LLY in Q4 2019 and held it in 11 quarters. The position peaked at $1.2M in Q2 2022. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Asset Allocation & Management Company reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Asset Allocation & Management Company sold 340 Eli Lilly shares in Q2 2026, an estimated $313K.
  • Asset Allocation & Management Company first reported a position in Eli Lilly in Q4 2019 and held it in 11 quarters.
  • Asset Allocation & Management Company's Eli Lilly position peaked at $1.2M in Q2 2022.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Asset Allocation & Management Company's 13F filing for Q2 2026, filed 15 Jul 2026.